ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC39172-10mg |
|
1093070-16-6 |
GRL0617
|
0 | C20H20N2O | |
GC39172-5mg |
|
1093070-16-6 |
GRL0617
|
0 | C20H20N2O | |
GC39171-100mg |
|
2351106-38-0 |
Pomalidomide-amido-C1-Br
|
0 | C15H12BrN3O5 | |
GC39171-50mg |
|
2351106-38-0 |
Pomalidomide-amido-C1-Br
|
0 | C15H12BrN3O5 | |
GC39171-10mg |
|
2351106-38-0 |
Pomalidomide-amido-C1-Br
|
0 | C15H12BrN3O5 | |
GC39171-5mg |
|
2351106-38-0 |
Pomalidomide-amido-C1-Br
|
0 | C15H12BrN3O5 | |
GC39170-100mg |
|
2369053-68-7 |
SMARCA-BD ligand 1 for Protac dihydrochloride
|
0 | C14H19Cl2N5O | |
GC39170-50mg |
|
2369053-68-7 |
SMARCA-BD ligand 1 for Protac dihydrochloride
|
0 | C14H19Cl2N5O | |
GC39170-10mg |
|
2369053-68-7 |
SMARCA-BD ligand 1 for Protac dihydrochloride
|
0 | C14H19Cl2N5O | |
GC39170-5mg |
|
2369053-68-7 |
SMARCA-BD ligand 1 for Protac dihydrochloride
|
0 | C14H19Cl2N5O | |
GC39169-100mg |
|
2259648-80-9 |
CC-92480
|
0 | C32H30FN5O4 | |
GC39169-50mg |
|
2259648-80-9 |
CC-92480
|
0 | C32H30FN5O4 | |
GC39169-10mg |
|
2259648-80-9 |
CC-92480
|
0 | C32H30FN5O4 | |
GC39169-5mg |
|
2259648-80-9 |
CC-92480
|
0 | C32H30FN5O4 | |
GC39168-100mg |
|
— |
GSK2945 hydrochloride
|
0 | C20H19Cl3N2O2S | |
GC39168-50mg |
|
— |
GSK2945 hydrochloride
|
0 | C20H19Cl3N2O2S | |
GC39168-10mg |
|
— |
GSK2945 hydrochloride
|
0 | C20H19Cl3N2O2S | |
GC39168-5mg |
|
— |
GSK2945 hydrochloride
|
0 | C20H19Cl3N2O2S | |
GC39167-100mg |
|
2086257-77-2 |
VBIT-4
|
0 | C21H23ClF3N3O3 | |
GC39167-50mg |
|
2086257-77-2 |
VBIT-4
|
0 | C21H23ClF3N3O3 | |